ストックスクリーナーアプリを入手
28.67
1.56%
0.44
前日終値:
$28.23
開ける：
$28.45
24時間の取引高:
58,346
Relative Volume:
0.53
時価総額：
$454.78M
収益：
$72.30M
当期純損益:
$-6.12M
株価収益率:
-15.60
EPS:
-1.8384
ネットキャッシュフロー:
$-41.16M
1週間 パフォーマンス:
+4.18%
1か月 パフォーマンス:
-2.28%
6か月 パフォーマンス:
+12.30%
1年 パフォーマンス:
+151.05%
1日の値動き範囲:
$28.40
$29.50
1週間の範囲:
$27.12
$30.18
52週間の値動き範囲:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
名前
Assembly Biosciences Inc
セクター
電話
(833) 409-4583
住所
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
28.67 | 454.78M | 72.30M | -6.12M | -41.16M | -1.8384 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-08-18 | 再開されました | H.C. Wainwright | Buy |
| 2025-03-25 | 開始されました | Guggenheim | Buy |
| 2024-09-20 | アップグレード | Jefferies | Hold → Buy |
| 2021-09-13 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | ダウングレード | Jefferies | Buy → Hold |
| 2020-10-19 | 開始されました | Truist | Buy |
| 2019-10-16 | 開始されました | Mizuho | Buy |
| 2018-11-19 | 開始されました | Leerink Partners | Outperform |
| 2018-10-08 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 開始されました | Robert W. Baird | Outperform |
| 2018-04-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 開始されました | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 開始されました | Jefferies | Buy |
| 2017-05-30 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Assembly Biosciences Inc (ASMB) 最新ニュース
Highs Report: Is Assembly Biosciences Inc being accumulated by smart moneyOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial - TipRanks
The Technical Signals Behind (ASMB) That Institutions Follow - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen - MarketBeat
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives - simplywall.st
Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB) - Seeking Alpha
Assembly Biosciences, Inc. 2025 Annual Report – Pipeline, Risk Factors, and Financial Outlook - Minichart
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS - MarketBeat
Assembly Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Assembly Biosciences Q4 Earnings: Profit Announced, Annual Loss NarrowsNews and Statistics - IndexBox
Assembly Biosciences (ASMB) launches $100M ATM via Jefferies under $400M shelf - Stock Titan
Assembly Biosciences: Fourth Quarter Financial Results Overview - Bitget
Assembly Biosciences: Q4 Earnings Snapshot - marketscreener.com
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights - The Manila Times
Assembly Biosciences 2025 net loss narrows - TradingView
Assembly Biosciences (NASDAQ: ASMB) advances antiviral pipeline and expands Gilead deal - Stock Titan
ASMB: 2025 revenue jumped to $72.3M, net loss shrank to $6.1M, and cash reserves rose to $248.1M - TradingView
Assembly Biosciences (Nasdaq: ASMB) slashes 2025 loss as Gilead deal lifts revenue - Stock Titan
Gilead deal hands Assembly Bio $35M as herpes program advances - Stock Titan
Panic Selling: Is Assembly Biosciences Inc being accumulated by smart money2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Risk Analysis: Can Assembly Biosciences Inc stock double in the next yearQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assembly Biosciences Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Farallon Capital Management LLC Takes $31.43 Million Position in Assembly Biosciences, Inc. $ASMB - MarketBeat
Commodore Capital LP Purchases Shares of 1,000,000 Assembly Biosciences, Inc. $ASMB - MarketBeat
Assembly Biosciences (ASMB) Projected to Post Earnings on Thursday - MarketBeat
Precision Trading with Assembly Biosciences Inc. (ASMB) Risk Zones - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Stock Report: Is Tecnoglass Inc forming a bullish divergenceWeekly Gains Report & Safe Entry Point Identification - baoquankhu1.vn
Published on: 2026-03-10 01:27:50 - baoquankhu1.vn
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes - MSN
ASMB Earnings History & Surprises | EPS & Revenue Results | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Assembly Biosciences identifies new compounds for HSV infection - bioworld.com
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
Patient Square Capital LP Invests $3.46 Million in Assembly Biosciences, Inc. $ASMB - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Will Assembly Biosciences Inc. stock benefit from infrastructure spendingWeekly Investment Recap & Safe Swing Trade Setup Alerts - mfd.ru
What is the target price for Assembly Biosciences Inc. stockQuarterly Market Review & AI Powered Buy and Sell Recommendations - mfd.ru
Trading the Move, Not the Narrative: (ASMB) Edition - Stock Traders Daily
Take Profit: Is Assembly Biosciences Inc stock trending bullishMarket Risk Report & Safe Capital Growth Plans - baoquankhu1.vn
Is Assembly Biosciences Inc. benefiting from innovation trendsLayoff News & Safe Entry Point Identification - mfd.ru
ASMB PE Ratio & Valuation, Is ASMB Overvalued - Intellectia AI
What is Assembly Biosciences Inc. s 5 year growth outlookJuly 2025 PostEarnings & Low Risk High Reward Ideas - mfd.ru
Bearish Setup: Can Assembly Biosciences Inc stock double in the next yearJuly 2025 Gainers & Real-Time Buy Signal Notifications - baoquankhu1.vn
Layoff Watch: Is Assembly Biosciences Inc benefiting from innovation trendsQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Assembly Biosciences Inc (ASMB) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):